Pesquisas alternativas:
compared cause » compared cases (Expandir a Pesquisa), complex cause (Expandir a Pesquisa), combined cause (Expandir a Pesquisa)
compared case » compared cases (Expandir a Pesquisa), compare care (Expandir a Pesquisa), compared can (Expandir a Pesquisa)
al compared » acl compared (Expandir a Pesquisa), ml compared (Expandir a Pesquisa), 5l compared (Expandir a Pesquisa)
cause new » causes new (Expandir a Pesquisa), use new (Expandir a Pesquisa), cause non (Expandir a Pesquisa)
case now » cases now (Expandir a Pesquisa), case non (Expandir a Pesquisa), case new (Expandir a Pesquisa)
3 al » a al (Expandir a Pesquisa), 3 yl (Expandir a Pesquisa), 3 a (Expandir a Pesquisa)
m al » m a (Expandir a Pesquisa), m l (Expandir a Pesquisa), a al (Expandir a Pesquisa)
compared cause » compared cases (Expandir a Pesquisa), complex cause (Expandir a Pesquisa), combined cause (Expandir a Pesquisa)
compared case » compared cases (Expandir a Pesquisa), compare care (Expandir a Pesquisa), compared can (Expandir a Pesquisa)
al compared » acl compared (Expandir a Pesquisa), ml compared (Expandir a Pesquisa), 5l compared (Expandir a Pesquisa)
cause new » causes new (Expandir a Pesquisa), use new (Expandir a Pesquisa), cause non (Expandir a Pesquisa)
case now » cases now (Expandir a Pesquisa), case non (Expandir a Pesquisa), case new (Expandir a Pesquisa)
3 al » a al (Expandir a Pesquisa), 3 yl (Expandir a Pesquisa), 3 a (Expandir a Pesquisa)
m al » m a (Expandir a Pesquisa), m l (Expandir a Pesquisa), a al (Expandir a Pesquisa)
1
Por Sharma, Hema, Turner, Claire E., Siggins, Matthew K., El-Bahrawy, Mona, Pichon, Bruno, Kearns, Angela, Sriskandan, Shiranee
Publicado no mSphere (2019)
“..., is the leading manifestation of toxic shock syndrome (TSS). Due to case rarity and a lack of tractable animal...”Publicado no mSphere (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Publicado em 2014
“.... Developmental cell 26, 381–392, doi:10.1016/j.devcel.2013.06.014 (2013). 2. Luo, W. et al. Pyruvate Kinase M2...”Obter o texto integral
Artigo
3
Publicado no Mol Cell Proteomics
(2017)
“... Hager(2), Armand Valsesia(2), Loic Dayon(2), Arne Astrup(3), Wim H. M. Saris(4), Florian Marty(1), Lukas...”Obter o texto integral
Artigo
4
Publicado no Mol Cell Proteomics
(2017)
“... repressing the mRNA of complex I's ND3 subunit. Our mtDNA-associated proteome shows that APEX labeling has...”Obter o texto integral
Artigo
5
Publicado no Cell Prolif
(2002)
“...) and SPF (r = 0.77). P53 immunoreactivity was present in 71.4% of the tumours, whereas 39.3% of cases were...”Obter o texto integral
Obter o texto integral
Artigo
6
Publicado no Mol Cell Proteomics
(2019)
“... separation on a PepMap C18 RSLC nanocolumn (15 cm × 75 μm, 3 μm, 100 Å, Dionex). Mobile phase A and B were...”Obter o texto integral
Artigo